
Crescent Capital (CCAP) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
7.1M
Net Income
3.9M
54.76%
EPS (Diluted)
$0.11
Balance Sheet Metrics
Total Assets
1.7B
Total Liabilities
939.4M
Shareholders Equity
727.1M
Debt to Equity
1.29
Cash Flow Metrics
Operating Cash Flow
2.0M
Free Cash Flow
-15.1M
Revenue & Profitability Trend
Crescent Capital Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 83.5M | 92.5M | 23.2M | 84.9M | 48.6M |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 5.2M | 4.9M | 4.5M | 4.9M | 4.4M |
Other Operating Expenses | 3.6M | 3.4M | 2.2M | -7.2M | -11.2M |
Total Operating Expenses | 8.8M | 8.3M | 6.7M | -2.3M | -6.8M |
Operating Income | - | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | - | - | - | - | - |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 74.7M | 84.1M | 16.5M | 87.3M | 55.4M |
Income Tax | 1.1M | 274.0K | 961.0K | 3.6M | 730.0K |
Effective Tax Rate % | 1.5% | 0.3% | 5.8% | 4.2% | 1.3% |
Net Income | 73.6M | 83.8M | 15.5M | 83.6M | 54.7M |
Net Margin % | 88.2% | 90.7% | 67.1% | 98.5% | 112.5% |
Key Metrics | |||||
EBITDA | - | - | - | - | - |
EPS (Basic) | $1.99 | $2.33 | $0.50 | $2.94 | $1.98 |
EPS (Diluted) | $1.99 | $2.33 | $0.50 | $2.94 | $1.98 |
Basic Shares Outstanding | 37061547 | 35928203 | 30887360 | 28477771 | 27681757 |
Diluted Shares Outstanding | 37061547 | 35928203 | 30887360 | 28477771 | 27681757 |
Income Statement Trend
Crescent Capital Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 10.1M | 7.8M | 6.4M | 10.1M | 1.9M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | - | - | - | - | - |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | - | - | - | - | - |
Total Assets | 1.7B | - | - | - | - |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 26.0M | 26.1M | 21.6M | 18.2M | 15.5M |
Short-term Debt | - | - | - | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | - | - | - | - | - |
Non-Current Liabilities | |||||
Long-term Debt | 875.8M | 844.8M | 654.5M | 631.0M | 471.9M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - | - |
Total Liabilities | 915.6M | - | - | - | - |
Equity | |||||
Common Stock | 37.0K | 37.0K | 31.0K | 31.0K | 28.0K |
Retained Earnings | -218.5M | -223.3M | -62.5M | -13.9M | -34.7M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 740.6M | 742.6M | 612.5M | 652.3M | 560.0M |
Key Metrics | |||||
Total Debt | 875.8M | 844.8M | 654.5M | 631.0M | 471.9M |
Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Crescent Capital Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 73.6M | 83.8M | 15.5M | 83.6M | 54.7M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 2.7M | -1.3M | 7.0M | -17.1M | 3.2M |
Operating Cash Flow | 59.0M | 73.5M | 13.0M | 54.6M | 54.3M |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Activities | |||||
Share Repurchases | - | - | 0 | 0 | -2.2M |
Dividends Paid | -75.2M | -64.6M | -55.3M | -47.7M | -42.6M |
Debt Issuance | 347.4M | 548.5M | 339.2M | 790.0M | 402.3M |
Debt Repayment | -312.2M | -565.0M | -318.1M | -628.6M | -336.1M |
Financing Cash Flow | -40.0M | -81.1M | -34.2M | 171.7M | 65.7M |
Free Cash Flow | 58.9M | 92.3M | 28.0M | -157.7M | -61.8M |
Net Change in Cash | 18.9M | -7.7M | -21.2M | 226.3M | 120.1M |
Cash Flow Trend
Crescent Capital Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.75
Forward P/E
7.51
Price to Book
0.78
Price to Sales
3.07
PEG Ratio
-0.50
Profitability Ratios
Profit Margin
24.12%
Operating Margin
75.45%
Return on Equity
5.98%
Return on Assets
5.27%
Financial Health
Current Ratio
1.31
Debt to Equity
122.44
Beta
0.60
Per Share Data
EPS (TTM)
$1.19
Book Value per Share
$19.55
Revenue per Share
$4.94
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
ccap | 562.2M | 12.75 | 0.78 | 5.98% | 24.12% | 122.44 |
BlackRock | 175.9B | 27.48 | 3.58 | 13.92% | 29.69% | 28.51 |
Brookfield | 103.4B | 232.59 | 2.46 | 0.95% | 0.73% | 156.81 |
WisdomTree | 2.0B | 32.71 | 4.31 | 14.12% | 16.25% | 115.79 |
SRH Total Return | 1.7B | 5.45 | 0.83 | 16.36% | 928.40% | 10.77 |
Sprott | 1.6B | 32.24 | 4.67 | 14.34% | 25.21% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.